Safety and Efficacy of Centanafadine Sustained-Release in Adults With Attention-Deficit Hyperactivity Disorder: Results of Phase 2 Studies

Código QR

Safety and Efficacy of Centanafadine Sustained-Release in Adults With Attention-Deficit Hyperactivity Disorder: Results of Phase 2 Studies

Sharon B Wigal,1 Tim Wigal,1 Mary Hobart,2 Jessica J Madera,3 Ross A Baker,3 Eva Kohegyi,3 Anthony McKinney,4 Timothy E Wilens5 1AVIDA Inc., Newport Beach, California, USA; 2Otsuka Pharmaceutical Development & Commercialization, Inc., Rockville, Maryland, USA; 3Otsuka Pharmaceutical Developm...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Wigal SB, Wigal T, Hobart M, Madera JJ, Baker RA, Kohegyi E, McKinney A, Wilens TE
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2020
Materias:	adhd rating scale-iv efficacy norepinephrine-dopamine-serotonin reuptake inhibitor tolerability Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/3e6cabdeeaf74eb7b39e551e80cb4f1e
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Selective serotonin reuptake inhibitors may lead to improved cataract surgery outcomes in patients with amblyopia
por: Xin KZ, et al.
Publicado: (2019)

The role of new antidepressants in clinical practice in Canada: a brief review of vortioxetine, levomilnacipran ER, and vilazodone
por: McIntyre RS
Publicado: (2017)

Serotonin Discharge Regulation by Additional Neurotransmitters of Rat Hippocampus Associated With the Continence Central Circuit
por: Jae Heon Kim, et al.
Publicado: (2021)

Review of Clinical Outcome Assessments in Pediatric Attention-Deficit/Hyperactivity Disorder
por: Markowitz JT, et al.
Publicado: (2020)

The noradrenergic paradox: implications in the management of depression and anxiety
por: Montoya A, et al.
Publicado: (2016)

Norepinephrine was superior in death risk reducing and hemodynamics compared to dopamine in treatment of patients with septic shock
por: Lu Xudong, et al.
Publicado: (2021)

A meta-analysis of effects of selective serotonin reuptake inhibitors on blood pressure in depression treatment: outcomes from placebo and serotonin and noradrenaline reuptake inhibitor controlled trials
por: Zhong Z, et al.
Publicado: (2017)

Genistein, a Natural Isoflavone, Alleviates Seizure-Induced Respiratory Arrest in DBA/1 Mice
por: Jialing Guo, et al.
Publicado: (2021)

Noradrenaline plays a critical role in the switch to a manic episode and treatment of a depressive episode
por: Kurita M
Publicado: (2016)

Attention deficit hyperactivity disorder and disordered eating behaviors: links, risks, and challenges faced
por: Ptacek R, et al.
Publicado: (2016)

Neurobiology of hedonic tone: the relationship between treatment-resistant depression, attention-deficit hyperactivity disorder, and substance abuse
por: Sternat T, et al.
Publicado: (2016)

THE CORRELATION OF PARENTING STYLE WITH COGNITIVE DEVELOPMENT IN CHILDREN WITH ATTENTION DEFICIT HYPERACTIVITY DISORDER
por: Fitri Genisti, et al.
Publicado: (2018)

High Risk for Attention-Deficit Hyperactive Disorder in Children with Strabismus: A Nationwide Cohort Study from the National Health Insurance Research Database
por: Chia-Ying Tsai, et al.
Publicado: (2021)

Efficacy of serotonin receptor agonists in the treatment of functional dyspepsia: a meta-analysis
por: Man Jin, et al.
Publicado: (2018)

Autistic Traits and Empathy in Children With Attention Deficit Hyperactivity Disorder, Autism Spectrum Disorder and Co-occurring Attention Deficit Hyperactivity Disorder/Autism Spectrum Disorder
por: Stefania Aiello, et al.
Publicado: (2021)

Trastorno por Déficit de Atención con Hiperactividad en Niños Escolarizados
por: URZÚA M,ALFONSO, et al.
Publicado: (2009)

Risk factors for the existence of attention deficit hyperactivity disorder symptoms in children with autism spectrum disorders
por: Lamanna AL, et al.
Publicado: (2017)

Effects of Celecoxib Adjunct to Selective Serotonin Reuptake Inhibitors on Obsessive-Compulsive Disorder
por: Najmeh Shahini, et al.
Publicado: (2021)

Pharmacogenetically Guided Escitalopram Treatment for Pediatric Anxiety Disorders: Protocol for a Double-Blind Randomized Trial
por: Jeffrey R. Strawn, et al.
Publicado: (2021)

Measures of executive functions predicting Attention-Deficit/Hyperactivity Disorder core symptoms
por: Tshikani T. Boshomane, et al.
Publicado: (2021)

Priapism associated with Risperidone: A case report
por: SH Hosseini, et al.
Publicado: (2006)

The association between polygenic scores for attention‐deficit/hyperactivity disorder and school performance: The role of attention‐deficit/hyperactivity disorder symptoms, polygenic scores for educational attainment, and shared familial factors
por: Andreas Jangmo, et al.
Publicado: (2021)

PREVALENCE OF AUTISM SPECTRUM DISORDERS (ASD) AND ATTENTION DEFICIT HYPERACTIVITY DISORDERS (ADHD) AMONG ADULT PSYCH
por: Sana Khan, et al.
Publicado: (2019)

Unique Trans-fatty Acid Profile in Children With Attention Deficit Hyperactivity Disorder
por: Ayelet Armon-Omer, et al.
Publicado: (2021)

Neuromolecular Underpinnings of Negative Cognitive Bias in Depression
por: Karolina Noworyta, et al.
Publicado: (2021)

Possible sertraline-induced extrapyramidal adverse effects in an adolescent
por: Wang LF, et al.
Publicado: (2016)

Attachment Representations in Children with and without Attention-Deficit/Hyperactivity Disorder (ADHD)
por: Tycho J. Dekkers, et al.
Publicado: (2021)

An observational study of duloxetine versus SSRI monotherapy in Japanese patients with major depressive disorder: subgroup analyses of treatment effectiveness for pain, depressive symptoms, and quality of life
por: Kuga A, et al.
Publicado: (2017)

Does early improvement in depressive symptoms predict subsequent remission in patients with depression who are treated with duloxetine?
por: Sueki A, et al.
Publicado: (2016)

Immunological indexes in evaluation of chronic pain syndrome”, Medical Immunology (Russia)
por: M. A. Мyagkova, et al.
Publicado: (2020)

Social function of adult men with attention-deficit/hyperactivity disorder in the context of military service
por: Noh GM, et al.
Publicado: (2018)

Biological Bases of Empathy and Social Cognition in Patients with Attention-Deficit/Hyperactivity Disorder: A Focus on Treatment with Psychostimulants
por: Pamela Fantozzi, et al.
Publicado: (2021)

Propiedades psicométricas: ADHD Rating Scale IV en formato autoreporte
por: Ramos G,Carlos, et al.
Publicado: (2016)

Orexin/Hypocretin Type 2 Receptor (HCRTR2) Gene as a Candidate Gene in Sertraline-Associated Insomnia in Depressed Patients
por: Firouzabadi N, et al.
Publicado: (2020)

Early symptom non-improvement and aggravation are associated with the treatment response to SSRIs in MDD: a real-world study
por: Yuan H, et al.
Publicado: (2019)

Application of a Conducting Poly-Methionine/Gold Nanoparticles-Modified Sensor for the Electrochemical Detection of Paroxetine
por: Saedah R. Al-Mhyawi, et al.
Publicado: (2021)

Effect of Depression and Antidepressants on Sexual Dysfunction in Men with Diabetes: A National Population-Based Cohort Study
por: Chung PL, et al.
Publicado: (2020)

A meta-analysis on the efficacy and safety of St John's wort extract in depression therapy in comparison with selective serotonin reuptake inhibitors in adults
por: Cui YH, et al.
Publicado: (2016)

SPECT Functional Neuroimaging Distinguishes Adult Attention Deficit Hyperactivity Disorder From Healthy Controls in Big Data Imaging Cohorts
por: Daniel G. Amen, et al.
Publicado: (2021)

Associations between attention‐deficit hyperactivity disorder (ADHD) symptom remission and white matter microstructure: A longitudinal analysis
por: Anne E. M. Leenders, et al.
Publicado: (2021)